Ultralife

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ultralife reports record sales in Q4 2022 amidst challenges

Ultralife Corporation delivered robust financial results in Q4 2022, showcasing growth in sales, segments, and profitability, despite facing challenges like supply chain disruptions and cybersecurity incidents.
The company's strategic strengths in market focus, operational resilience, and debt reduction plans position it well to capitalize on opportunities for further growth and innovation in the future.
Analysts' inquiries highlighted areas for improvement and risk mitigation, signaling a proactive approach by Ultralife to address challenges and drive sustainable value creation.

Ultralife reports revenue growth amidst cyber attack challenges in Q1

Ultralife resilient in Q1 2023 with revenue growth despite cyber attack impact.
Strong government defense sales offset commercial sales decline.
Company focused on executing backlog, improving margins, and driving growth.
Challenges include cyber incident impact, net loss, and supply chain issues.

Ultralife reports stellar Q2 results, eyes margin improvement and growth

Ultralife Corporation delivered exceptional Q2 2023 results, marked by substantial revenue growth, profitability, and a record backlog, showcasing strong market demand.
The company's focus on improving gross margins, efficient cost management, and growth initiatives in key segments positions it well for future success and market leadership.
While challenges like maintaining margins and executing backlog exist, Ultralife's solid financial performance, operational stability, and growth opportunities paint a positive outlook.
By leveraging opportunities for margin enhancement, market expansion, and innovation, Ultralife can navigate challenges and capitalize on its strengths for sustained growth and profitability.

Ultralife reports robust Q3 performance, eyes growth through strategic initiatives

Ultralife's Q3 2023 performance reflects strong financial health, with notable improvements in gross margin, operating profit, and revenue growth.
The company's strategic focus on debt reduction, profitability enhancement, and organic growth initiatives underscores a promising outlook for future success.
Challenges lie in consistently improving gross margins, maintaining backlog levels, and effectively balancing debt repayment with growth investments.

Ultralife (ULBI) posts strong Q4 results, eyes growth opportunities

Ultralife (ULBI) delivered robust financial performance in Q4 and full-year 2023, driven by strong sales growth and margin improvement.
The company faces challenges in production capacity, operational efficiency, and project launches, requiring ongoing attention.
Strategic focus on gross margin enhancement, organic growth, and new product opportunities present avenues for future expansion.
With a solid financial position, Ultralife is well-positioned to capitalize on market opportunities and navigate potential challenges.

Ultralife reports robust Q1 earnings, poised for strategic growth

Ultralife Corporation's Q1 2024 performance reflects strong revenue growth, margin improvement, and profitability milestones.
The company's focus on key segments like Battery & Energy Products and Communication Systems drove significant revenue increases.
While challenges like sustaining margins and managing expenses exist, Ultralife is well-positioned to capitalize on growth opportunities.
Investors should take note of Ultralife's turnaround in earnings and strategic positioning for future growth.

Ultralife posts robust Q2 results, eyes M&A opportunities amid challenges

Ultralife's Q2 performance showcased strong sales, debt reduction, and margin improvement.
While facing challenges in the Communications Systems segment, the company's strategic focus on debt management and market diversification presents growth opportunities.
Investors should take note of Ultralife's solid financial position and potential for future expansion through M&A.

Ultralife reports mixed Q3 results, eyes growth through Electrochem acquisition

Ultralife's Q3 performance reflects mixed results with revenue growth in Battery & Energy Products but decline in Communication Systems.
The company faces challenges in revenue diversification, margin pressure, and increased operating expenses.
However, strategic initiatives and the Electrochem acquisition offer growth opportunities in high-reliability markets.
Overall, Ultralife's focus on efficiency and profitability amidst challenges positions it for long-term success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEWARK, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2023 before the market opens on Thursday, July 27, 2023.

Ultralife Corporation to Report Second Quarter Results on July 27, 2023

Ultralife Corporation (NASDAQ:ULBI ) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2023 Results Conference Call.

Ultralife Corporation (ULBI) Q1 2023 Results - Earnings Call Transcript

NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2023 before the market opens on Thursday, April 27, 2023.

Ultralife Corporation to Report First Quarter Results on April 27, 2023

Ultralife Corporation (NASDAQ:ULBI ) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Josh Sullivan - Benchmark Company John Deysher - Pinnacle Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Fourth Quarter 2022 Results Conference Call.

Ultralife Corporation (ULBI) Q4 2022 Earnings Call Transcript

NEWARK, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) announced today the addition of Janie Goddard as Director of the Company.

Ultralife Corporation Adds Janie Goddard to its Board of Directors

NEWARK, N.Y., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2022 before the market opens on Thursday, March 2, 2023. We are reporting our quarterly results later than our customary reporting practice due to illnesses experienced by some members of our Accounting/Finance Team causing delays in the year-end closing and audit.

Ultralife Corporation to Report Fourth Quarter Results on March 2, 2023

NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation (“Ultralife” or the “Company”) (NASDAQ: ULBI) has appointed Michael E. Manna as the Company's President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addition to his new role, Mike Manna will retain his leadership position for the Company's Battery & Energy Products segment which he held prior to his appointment as President & CEO.

Ultralife Corporation Names Michael E. Manna President & CEO

Ultralife Corporation (NASDAQ:ULBI ) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Popielec - President and Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company, LLC Operator Hello and welcome to Ultralife Corporation Third Quarter 2022 Earnings Release. My name is Pricilla and I will be your coordinator for today's event.

Ultralife Corporation (ULBI) CEO Michael Popielec on Q3 2022 Results - Earnings Call Transcript

NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $5.5 million to supply its vehicle communications systems to a global prime defense contractor for the U.S. Army. Ultralife's vehicle communications platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence and be completed in 2023.

Ultralife Corporation Receives $5.5 Million Communications Systems Contract

NEWARK, N.Y., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2022, before the market opens on Thursday, October 27, 2022.

Ultralife Corporation to Report Third Quarter Results on October 27, 2022

NEWARK, N.Y., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a contract valued at approximately $7.5 million to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for an ongoing government/defense modernization program. Deliveries are expected to commence in the fourth quarter of 2022 and continue through the first half of 2023.

Ultralife Corporation Receives $7.5 Million Communications Systems Contract

Ultralife Corporation. (NASDAQ:ULBI ) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Popielec - President and Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to this Ultralife Corporation Second Quarter 2022 Earnings Release Conference Call.

Ultralife Corporation (ULBI) CEO Michael Popielec on Q2 2022 Results - Earnings Call Transcript

NEWARK, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $4.6 million to supply its Vehicle Amplifier-Adaptors (“VAA”) to a global prime defense contractor. Ultralife's VAA platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence in 2022.

Ultralife Corporation Awarded $4.6 Million Communications Systems Vehicle Amplifier-Adaptor Order

NEWARK, N.Y., July 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2022, before the market opens on Thursday, July 28, 2022.

Ultralife Corporation to Report Second Quarter Results on July 28, 2022

Ultralife Corporation (NASDAQ:ULBI ) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Popielec - President and Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company Operator Good day, and welcome to this Ultralife Corporation First Quarter 2022 Earnings Release Conference Call. At this time, for opening remarks and introductions, I'd like to turn the call over to Ms.

Ultralife Corporation (ULBI) CEO Mike Popielec on Q1 2022 Results - Earnings Call Transcript

NEWARK, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2022, before the market opens on Thursday, April 28, 2022.

Ultralife Corporation to Report First Quarter Results on April 28, 2022

Ultralife Corporation's (ULBI) CEO Mike Popielec on Q4 2021 Results - Earnings Call Transcript

NEWARK, N.Y., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2021 before the market opens on Thursday, February 3, 2022.

Ultralife Corporation to Report Fourth Quarter Results on February 3, 2022

Ultralife Corp (NASDAQ: ULBI) has acquired Excell Battery Group for $23.5 million in cash. Excell is an independent designer and manufacturer of high-performance smart battery systems, battery packs, and monitoring systems to customer specifications.

Ultralife Acquires Excell Battery For $23.5M; Bags $9.9M Contract For BA-5390 Batteries

Advances Ultralife's Commercial Revenue Diversification Strategy Advances Ultralife's Commercial Revenue Diversification Strategy

Ultralife Corporation Acquires Excell Battery Group

NEWARK, N.Y., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a firm-fixed price, indefinite-delivery/indefinite-quantity contract not to exceed $9.9 million from the U.S. Government's Defense Logistics Agency (DLA) for its lithium manganese dioxide, non-rechargeable BA-5390 batteries. The award consists of a three-year base contract with two one-year option periods. Actual delivery orders including the amounts and timing under this contract are at the discretion of the DLA.

Ultralife Corporation Receives Award for Its BA-5390 Military Batteries from Defense Logistics Agency

Ultralife Corporation (ULBI) CEO Mike Popielec on Q3 2021 Results - Earnings Call Transcript

NEWARK, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $4.2 million to supply its Vehicle Amplifier-Adaptors (“VAA”) to Thales Defense & Security, Inc., a global leader in the development, manufacture, and support of combat-proven, software-defined radio equipment, for the U.S. Army's Leader Radio program. Shipments are expected to commence in 2022.

Ultralife Corporation Awarded $4.2 Million Communications Systems Leader Radio Order

NEWARK, N.Y., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2021, before the market opens on Thursday, October 28, 2021.

Ultralife Corporation to Report Third Quarter Results on October 28, 2021

Ultralife Corporation (ULBI) CEO Mike Popielec on Q2 2021 Results - Earnings Call Transcript

News for Ultralife Stock (ULBI)